๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of hexamethylmelamine (NSC 13875)

โœ Scribed by W. L. Wilson; J. M. Schroeder; H. F. Bisel; R. Mrazek; R. P. Hummel

Publisher
John Wiley and Sons
Year
1969
Tongue
English
Weight
407 KB
Volume
23
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase II study of phenesterin (NSC-104
A phase II study of phenesterin (NSC-104469)
โœ Bennett, J. M. ;Frank, J. ;Sears, M. ;Lagakos, S. W. ;Horton, J. ;Colsky, J. ;Ha ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 327 KB

## Abstract Phenesterin was evaluated in 222 patients with two different dosage regimens, one by daily treatment and the other with an intermittent schedule. Toxicity was moderate with both programs. The largest group of patients treated had breast cancer; they experienced a 10% response rate. Of i

Phase I study of L-alanosine (NSC 15353)
Phase I study of L-alanosine (NSC 15353)
โœ Michael A. Goldsmith; Takao Ohnuma; Melvin Spigelman; Ezra M. Greenspan; James F ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 234 KB ๐Ÿ‘ 1 views
Phase II study of high-dose tamoxifen (N
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanoma
โœ Edward T. Creagan; James N. Ingle; David L. Ahmann; Stephanie J. Green ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 206 KB ๐Ÿ‘ 3 views

Seventeen patients with disseminated malignant melanoma received a daily oral regimen of tamoxifen, 100 mg/m2. All patients had prior chemotherapy and predominantly visceral involvement. None of the patients had an objective regression and most (71%) had progressive disease at the time of first reas